These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15705254)

  • 1. Ten common questions about hypertrophic cardiomyopathy...and misconceptions.
    Maron BJ
    Cardiol Rev; 2005; 13(2):59-60. PubMed ID: 15705254
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    O'Mahony C; Elliott PM
    Heart; 2014 Feb; 100(3):254-60. PubMed ID: 23574968
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
    Maron BJ
    Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
    [No Abstract]   [Full Text] [Related]  

  • 4. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
    Maron BJ; Estes NA; Maron MS; Almquist AK; Link MS; Udelson JE
    Circulation; 2003 Jun; 107(23):2872-5. PubMed ID: 12814983
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sudden death in hypertrophic myocardiopathy].
    Cardim N; Longo S; Gouveia D; Lousada N; Ferreira T; Pereira AT; Correia JM
    Rev Port Cardiol; 1995 Sep; 14(9):655-9. PubMed ID: 7576766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Syncope of uncertain cause and sudden cardiac death in young patients].
    Schimpf R; Wolpert C; Veltmann C; Kuschyk J; Borggrefe M
    Dtsch Med Wochenschr; 2006 May; 131(18):1040-6. PubMed ID: 16673231
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator].
    Manovel-Sánchez AJ; Pedrote-Martínez A; Arana-Rueda E; Errazquin-Sáenz de Tejada F
    Rev Esp Cardiol; 2007 Jul; 60(7):784; author reply 785. PubMed ID: 17663866
    [No Abstract]   [Full Text] [Related]  

  • 9. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?
    Maron BJ; Olivotto I; Maron MS
    Eur Heart J; 2006 Aug; 27(16):1895-7. PubMed ID: 16818455
    [No Abstract]   [Full Text] [Related]  

  • 10. Sudden death in hypertrophic cardiomyopathy.
    Watkins H
    N Engl J Med; 2000 Feb; 342(6):422-4. PubMed ID: 10666434
    [No Abstract]   [Full Text] [Related]  

  • 11. My approach to clinical management of hypertrophic cardiomyopathy.
    Maron MS
    Trends Cardiovasc Med; 2014 Oct; 24(7):314-5. PubMed ID: 25218674
    [No Abstract]   [Full Text] [Related]  

  • 12. Device therapy in hypertrophic cardiomyopathy.
    Beadle R; Williams L
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1767-75. PubMed ID: 21108558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden cardiac death in hypertrophic cardiomyopathy.
    Malanuk RM; Nielsen CD; Spencer WH
    J S C Med Assoc; 2001 Oct; 97(10):424-7. PubMed ID: 11688312
    [No Abstract]   [Full Text] [Related]  

  • 14. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
    Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
    J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable defibrillators in hypertrophic cardiomyopathy.
    Grace A
    Heart; 2009 May; 95(9):695-6. PubMed ID: 19282312
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].
    Maron BJ
    Rev Esp Cardiol; 2006 Jun; 59(6):527-30. PubMed ID: 16790193
    [No Abstract]   [Full Text] [Related]  

  • 18. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.
    Cotiga D; Ehlert F; Sherrid M
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():55-60. PubMed ID: 17162272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation].
    Jastrzebski M; Czarnecka D; Bacior B; Petkow-Dimitrow P; Wilczek R; Kawecka-Jaszcz K
    Kardiol Pol; 2005 Aug; 63(2):191-5; discussion 196. PubMed ID: 16136416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment in hypertrophic cardiomyopathy.
    Saumarez RC
    Heart; 2009 Mar; 95(5):421; author reply 421. PubMed ID: 19218265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.